专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明授权

US07858122B2 Extended release formulation of levetiracetam 有权
标题翻译：左乙拉西坦的延长释放制剂
公开(公告)号：US07858122B2
公开(公告)日：2010-12-28
申请号：US11215947
申请日：2005-08-31
申请人： Rajesh Kshirsagar , Mayank Joshi , Yogesh Raichandani
发明人： Rajesh Kshirsagar , Mayank Joshi , Yogesh Raichandani
IPC分类号： A01N43/36 , A61K31/40 , A61K9/22
CPC分类号： A61K31/4015 , A61K9/1635 , A61K9/2054 , A61K9/2077 , A61K9/2866
摘要： An extended release pharmaceutical composition of Levetiracetam with once a day dosage regime and the process of preparing it. The extended release tablet of Levetiracetam is with the core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients blood plasma, which comprises administering orally to a patient in need thereof, an extended release tablet that provides a peak blood plasma level of Levetiracetam in from about eight to about Sixteen hours. The core is prepared by Wet granulation, Dry granulation or Direct compression and optionally the tablet core is coated either in an coating pan or in and Fluidized bed system.
摘要翻译：延长释放的左乙拉西坦药物组合物，每日一次剂量方案及其制备方法。左乙拉西坦的延长释放片剂包含左乙拉西坦和水分散速率控制聚合物的核心，并且片芯任选地功能性涂覆，包括水不可分散和/或水分散性聚合物的组合。它通过消除患者血浆中药物浓度的波谷和峰值，在二十四小时内提供延长的治疗有效血浆水平，减少神经精神不良事件的发生率，其包括向有需要的患者口服延长释放片剂其提供左乙拉西坦的血浆血浆水平高达约8至16小时。核心通过湿法造粒，干法制粒或直接压片制备，并且任选地，片芯包被在涂布盘或流化床系统中。

12. 发明授权

US07647466B1 Linear space allocation mechanisms in data space 有权
标题翻译：数据空间中的线性空间分配机制
公开(公告)号：US07647466B1
公开(公告)日：2010-01-12
申请号：US11540832
申请日：2006-09-28
申请人： Mandavilli Navneeth Rao , Mayank Joshi
发明人： Mandavilli Navneeth Rao , Mayank Joshi
IPC分类号： G06F12/00
CPC分类号： G06F17/30312 , G06F11/1458 , G06F2201/84
摘要： An indication to allocate storage is received, where the storage is to be used to store previous version data associated with a protected data set. One or more storage groups are allocated of at least a prescribed allocation group size and comprising a set of physically contiguous storage locations.
摘要翻译：接收到分配存储的指示，其中存储用于存储与受保护数据集相关联的先前版本数据。一个或多个存储组被分配至少一个规定的分配组大小并且包括一组物理上连续的存储位置。

13. 发明申请

US20070110808A1 Extended release osmo-microsealed formulation 审中-公开
标题翻译：延长释放的渗透微密封制剂
公开(公告)号：US20070110808A1
公开(公告)日：2007-05-17
申请号：US10563631
申请日：2004-05-14
申请人： Sampad Bhattacharya , Sridhar Gummudavelli , Mayank Joshi , John Egbert
发明人： Sampad Bhattacharya , Sridhar Gummudavelli , Mayank Joshi , John Egbert
IPC分类号： A61K31/137 , A61K9/24
CPC分类号： A61K9/2846 , A61K9/0004 , A61K9/2077 , A61K9/2081 , A61K9/5042 , A61K9/5047
摘要： The extended release osmo-microsealed formulation includes three controlled release systems associated in series. First, there is an inner solid particulate phase containing Venlafaxine Hydrochloride (Active), and one or more hydrophobic polymers, one or more diluents required to increase the bulk one or more osmogen (agents which can generate osmotic pressure across the hydrophobic coating) and one or more binder polymers essentially to provide strength/hardness to the particle. Second, there is an outer solid continuous phase including one or more hydrophilic polymers, that is further compressed into a tablet. Third, there is an optional functional coat surrounding the tablet. The process/method for forming the Osmo-microsealed extended release delivery system and the process for using such system for treating human ailment/depression are also provided.
摘要翻译：延长释放的渗透微密封制剂包括三个相互联系的控制释放系统。首先，存在含有盐酸文拉法辛（活性）的内固体颗粒相和一种或多种疏水性聚合物，一种或多种稀释剂，以增加体积的一种或多种渗透剂（可以在疏水涂层上产生渗透压的试剂）和一种或更多的粘合剂聚合物基本上为颗粒提供强度/硬度。第二，存在包含一种或多种亲水性聚合物的外部固体连续相，其进一步压缩成片剂。第三，围绕平板电脑有一个可选的功能外套。还提供了用于形成Osmo-微密封延长释放递送系统的方法/方法以及使用该系统治疗人类疾病/抑郁症的方法。

14. 发明申请

US20060246197A1 Process and composition of preparing granular sucralose for emulating table sugar 审中-公开
公开(公告)号：US20060246197A1
公开(公告)日：2006-11-02
申请号：US11296580
申请日：2005-12-07
申请人： Rajesh Kshirsagar , Mayank Joshi , Amresh Kumar
发明人： Rajesh Kshirsagar , Mayank Joshi , Amresh Kumar
IPC分类号： A23L1/236
CPC分类号： A23L27/37 , A23V2002/00 , A23V2200/132 , A23V2250/264
摘要： A low-calorie solid, pourable composition for emulating sugar, the composition comprising an intense sweetener and at least one low-calorie bulking agent selected from maltodextrin, magnesium oxide, magnesium carbonate, calcium stearate, colloidal silicon dioxide and starch or combinations thereof, and a process for the preparation of said composition.

15. 发明申请

US20110064807A1 EXTENDED RELEASE FORMULATION OF LEVETIRACETAM 审中-公开
标题翻译：延长释放配方的利多卡因
公开(公告)号：US20110064807A1
公开(公告)日：2011-03-17
申请号：US12942585
申请日：2010-11-09
申请人： Rajesh Kshirsagar , Mayank Joshi , Yogesh Raichandani
发明人： Rajesh Kshirsagar , Mayank Joshi , Yogesh Raichandani
IPC分类号： A61K9/28 , A61K31/4015 , A61K9/36 , A61P25/08
CPC分类号： A61K31/4015 , A61K9/1635 , A61K9/2054 , A61K9/2077 , A61K9/2866
摘要： An extended release pharmaceutical composition of Levetiracetam with once a day dosage regime and the process of preparing it. The extended release tablet of Levetiracetam is with the core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients blood plasma, which comprises administering orally to a patient in need thereof, an extended release tablet that provides a peak blood plasma level of Levetiracetam in from about eight to about Sixteen hours. The core is prepared by Wet granulation, Dry granulation or Direct compression and optionally the tablet core is coated either in an coating pan or in and Fluidized bed system.
摘要翻译：延长释放的左乙拉西坦药物组合物，每日一次剂量方案及其制备方法。左乙拉西坦的延长释放片剂包含左乙拉西坦和水分散速率控制聚合物的核心，并且片芯任选地功能性涂覆，包括水不可分散和/或水分散性聚合物的组合。它通过消除患者血浆中药物浓度的波谷和峰值，在二十四小时内提供延长的治疗有效血浆水平，减少神经精神不良事件的发生率，其包括向有需要的患者口服延长释放片剂其提供左乙拉西坦的血浆血浆水平高达约8至16小时。核心通过湿法造粒，干法制粒或直接压片制备，并且任选地，片芯包被在涂布盘或流化床系统中。

16. 发明申请

US20100077173A1 Linear space allocation mechanisms in data space 有权
公开(公告)号：US20100077173A1
公开(公告)日：2010-03-25
申请号：US12592215
申请日：2009-11-19
申请人： Mandavilli Navneeth Rao , Mayank Joshi
发明人： Mandavilli Navneeth Rao , Mayank Joshi
IPC分类号： G06F12/02 , G06F12/00
CPC分类号： G06F17/30312 , G06F11/1458 , G06F2201/84
摘要： An indication to allocate storage is received, where the storage is to be used to store previous version data associated with a protected data set. One or more storage groups are allocated of at least a prescribed allocation group size and comprising a set of physically contiguous storage locations.

17. 发明授权

US07568156B1 Language rendering 有权
标题翻译：语言呈现
公开(公告)号：US07568156B1
公开(公告)日：2009-07-28
申请号：US11054331
申请日：2005-02-08
申请人： Wolfgang Fischer , Matt Buchman , Thomas Dixon Hutchinson , Mayank Joshi , Scott Lee , Tom Pohorsky , Merlinda Poon , Bala Vijayakumar
发明人： Wolfgang Fischer , Matt Buchman , Thomas Dixon Hutchinson , Mayank Joshi , Scott Lee , Tom Pohorsky , Merlinda Poon , Bala Vijayakumar
IPC分类号： G06F17/00
CPC分类号： G06F17/2223
摘要： In some embodiments, a technique for processing a character comprises receiving a character; determining whether the character is in a predetermined language; transforming the character to a symbol associated with a private area of Unicode if it is determined that the character is not in the predetermined language; and storing a result of the transformation.
摘要翻译：在一些实施例中，一种用于处理字符的技术包括：接收字符; 确定所述角色是否是预定语言; 如果确定该字符不是预定语言，则将该字符转换为与该专用区域相关联的符号; 并存储转换的结果。

18. 发明申请

US20060165796A1 Extended release formulation of levetiracetam 有权
标题翻译：左乙拉西坦的延长释放制剂
公开(公告)号：US20060165796A1
公开(公告)日：2006-07-27
申请号：US11215947
申请日：2005-08-31
申请人： Rajesh Kshirsagar , Mayank Joshi , Yogesh Raichandani
发明人： Rajesh Kshirsagar , Mayank Joshi , Yogesh Raichandani
IPC分类号： A61K31/4015 , A61K9/24
CPC分类号： A61K31/4015 , A61K9/1635 , A61K9/2054 , A61K9/2077 , A61K9/2866
摘要： An extended release pharmaceutical composition of Levetiracetam with once a day dosage regime and the process of preparing it. The extended release tablet of Levetiracetam is with the core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients blood plasma, which comprises administering orally to a patient in need thereof, an extended release tablet that provides a peak blood plasma level of Levetiracetam in from about eight to about Sixteen hours. The core is prepared by Wet granulation, Dry granulation or Direct compression and optionally the tablet core is coated either in an coating pan or in and Fluidized bed system.
摘要翻译：延长释放的左乙拉西坦药物组合物，每日一次剂量方案及其制备方法。左乙拉西坦的延长释放片剂包含左乙拉西坦和水分散速率控制聚合物的核心，并且片芯任选地功能性涂覆，包括水不可分散和/或水分散性聚合物的组合。它通过消除患者血浆中药物浓度的波谷和峰值，在二十四小时内提供延长的治疗有效血浆水平，减少神经精神不良事件的发生率，其包括向有需要的患者口服延长释放片剂其提供左乙拉西坦的血浆血浆水平高达约8至16小时。核心通过湿法造粒，干法制粒或直接压片制备，并且任选地，片芯包被在涂布盘或流化床系统中。

19. 发明申请

US20060110454A1 Extended release formulation of pramipexole dihydrochloride 审中-公开
标题翻译：普拉克索二盐酸盐的延长释放制剂
公开(公告)号：US20060110454A1
公开(公告)日：2006-05-25
申请号：US11260066
申请日：2005-10-27
申请人： Rajesh Kshirsagar , Mayank Joshi , Amresh Kumar
发明人： Rajesh Kshirsagar , Mayank Joshi , Amresh Kumar
IPC分类号： A61K31/428 , A61K9/22
CPC分类号： A61K9/5078 , A61K9/2081 , A61K9/5047 , A61K31/428
摘要： An extended release composition of Pramipexole or a pharmaceutical acceptable salt thereof, wherein the active agent is coated on a non pareil inert core, the drug loaded core is further coated with a polymeric layer which enables the release of the active agent over an extended period and optionally the extended release pellets being further blended with suitable excipients and compressed into a multi unit tablet and processes for the preparation of the said composition.
摘要翻译：普拉克索或其药学上可接受的盐的延长释放组合物，其中所述活性剂涂覆在非帕里尔惰性核心上，所述药物负载核心还进一步涂覆聚合物层，所述聚合物层能够在长时间内释放活性剂，任选地，延长释放丸粒进一步与合适的赋形剂混合并压制成多单位片剂并制备所述组合物。

20. 发明申请

US20090220663A1 Process and composition of preparing granular sucralose for emulating table sugar 审中-公开
标题翻译：制备颗粒状三氯蔗糖的工艺和组成，用于模拟桌面糖
公开(公告)号：US20090220663A1
公开(公告)日：2009-09-03
申请号：US10558514
申请日：2005-10-10
申请人： Rajesh Kshirsagar , Mayank Joshi , Amresh Kumar
发明人： Rajesh Kshirsagar , Mayank Joshi , Amresh Kumar
IPC分类号： A23L1/236 , A23L1/0522 , A23P1/02
CPC分类号： A23L27/37 , A23V2002/00 , A23V2200/132 , A23V2250/264
摘要： A low-calorie solid, pourable composition for emulating sugar, the composition comprising an intense sweetener and at least one low-calorie bulking agent selected from maltodextrin, magnesium oxide, magnesium carbonate, calcium stearate, colloidal silicon dioxide and starch or combinations thereof, and a process for the preparation of said composition.
摘要翻译：一种用于模拟糖的低热量固体可倾倒组合物，该组合物包含强甜味剂和至少一种选自麦芽糖糊精，氧化镁，碳酸镁，硬脂酸钙，胶体二氧化硅和淀粉或其组合的低热量填充剂，以及一种制备所述组合物的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式